Lactobacillus gallinarum -derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis.
Winnie FongQing LiFenfen JiWei LiangHarry Cheuk Hay LauXing KangWeixin LiuKenneth Kin-Wah ToZhong ZuoXiao-Xing LiXiang ZhangJoseph Jao Yiu SungJun YuPublished in: Gut (2023)
is a potential adjuvant to augment anti-PD1 efficacy against CRC.